0000000000306187

AUTHOR

S. S. Johannsen

showing 2 related works from this author

ADMA and arginine derivatives in relation to non-invasive vascular function in the general population.

2015

Nitric oxide produced from l-arginine is central to vascular homeostasis. Little is known about the relationship between arginine derivatives including asymmetric dimethylarginine (ADMA) and non-invasive vascular function measures in the general population.In 5000 individuals (median age 56; 25th/75th percentile: 46, 65; 49% women) taking part in the population-based Gutenberg Health Study (Mainz area, Germany), we measured the relationship between the arginine derivatives asymmetric dimethylarginine (ADMA), N-monomethyl l-arginine (NMMA), symmetric dimethylarginine (SDMA) and l-arginine with flow-mediated dilation (FMD) and peripheral arterial tonometry (PAT). Weak bivariate correlations w…

0301 basic medicineAdultMalePercentilemedicine.medical_specialtyArginineBrachial ArteryPopulationVasodilation030204 cardiovascular system & hematologyArginine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicine.arteryGermanyPrevalenceMedicineHumansBrachial arteryEnzyme InhibitorseducationAgedRetrospective Studieseducation.field_of_studybiologybusiness.industryMiddle AgedNitric oxide synthaseVasodilation030104 developmental biologyEndocrinologyCross-Sectional StudieschemistryCardiovascular DiseasesPopulation Surveillancebiology.proteinFemaleNitric Oxide SynthaseCardiology and Cardiovascular MedicinebusinessAsymmetric dimethylarginineBody mass indexBlood Flow VelocityAtherosclerosis
researchProduct

High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibr…

2015

To evaluate the diagnostic performance of high-sensitivity troponin I (hsTnI) and other novel biomarkers for diagnosing non-ST-segment elevation myocardial infarction (NSTEMI) in patients with atrial fibrillation.In an acute chest pain cohort (N=1673), mean age 61.4±13.6 (34% female), we measured hsTnI and 13 established and novel biomarkers reflecting ischaemia, necrosis, inflammation, myocardial stress, angiogenesis on admission and after three hours in order to investigate their diagnostic accuracy for NSTEMI.In atrial fibrillation patients (N=299) hsTnI on admission had the best discriminatory ability for NSTEMI (area under the curve 0.97) with only two novel biomarkers, copeptin and he…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineFatty Acid-Binding ProteinsSensitivity and SpecificityBiomarkers PharmacologicalAngina Pectoris03 medical and health sciences0302 clinical medicineCopeptinTroponin TInternal medicineTroponin IAtrial FibrillationmedicineST segmentHumans030212 general & internal medicineMyocardial infarctionProspective StudiesNon-ST Elevated Myocardial InfarctionAgedFibrillationbiologyTroponin Tbusiness.industryGlycopeptidesAtrial fibrillationGeneral Medicinemedicine.diseaseTroponinEarly DiagnosisArea Under Curvebiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessFatty Acid Binding Protein 3European heart journal. Acute cardiovascular care
researchProduct